SPHK1 and cancer: As more studies begin to elucidate the role of caspase‐2 in cancer, it will be interesting to investigate how levels of sphingolipid proteins that are regulated by caspase‐2 such as SK1 and CERT and subsequent sphingolipid levels are altered in these cancers and whether these alterations play an important role in tumorigenesis or response to therapy.